Eli Lilly and Company's strong Phase 3 diabetes drug results boost its GLP-1 franchise. Click for my updated look at LLY ...

Researchers are warning of a diabetes crisis, as nearly half of 1.3 billion affected adults go undiagnosed, with young people and low-income regions most at risk.

Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking ...

MADRID — High-quality data from European diabetes registries are essential for informed decision-making in clinical practice, research, policy, and regulation, experts said during a session at the ...

Glooko announced the launch of the new version of its Glooko Web Application platform this morning. The site aims to give users more resources with a streamlined navigation tool and an assortment of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The tool predicts changes in A1C in the next 90 days and ...

India has launched its first-ever diabetes biobank in Chennai, a major step toward understanding and tackling one of the country's most pressing health concerns. This groundbreaking initiative is a ...

New, more affordable continuous glucose monitor to help people with Type 2 diabetes better manage their condition ...

Over time, you notice your blood sugar levels landing outside the 70 to 140 mg/dL range. This can be a clue to insulin ...